O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional
Revista ft · 16.05.2026 · 30 (158) · 01-19
DOI: 10.69849/d1av6113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 16.05.2026. Verfasst von Danilo Conceição Silva und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity is a multifactorial chronic disease and a public health challenge, which has driven the use of pharmacological strategies such as GLP-1 receptor agonists, specifically semaglutide and tirzepatide. This integrative literature review analyzed studies published between 2018 and 2025 to evaluate the therapeutic application, risks, and the pharmacist's role in this scenario. The results indicate that irrational use increases the risk of serious adverse events, such as gastroparesis, pancreatitis, and biliary complications. Furthermore, it evidenced that high aesthetic demand, driven by unrealistic beauty standards, exacerbates socioeconomic inequalities, as access is mediated by income. This process transforms essential medicines into restricted consumer items, harming patients with real clinical needs. It is concluded that the pharmacist's performance is essential in promoting rational use, acting in health education, monitoring adverse reactions, and ensuring patient safety in the face of the medicalization of aesthetics.
Zitieren
APA
Silva, D. C., Conceição, V. C. A. D., Jesus, L. O. D., Lima, M. J. D. J., & Andrade, L. S. M. (2026). O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional. Revista ft, 30(158), 01-19. https://doi.org/10.69849/d1av6113
Vancouver
Silva DC, Conceição VCAD, Jesus LOD, Lima MJDJ, Andrade LSM. O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional. Revista ft. 2026;30(158):01-19. doi:10.69849/d1av6113
BibTeX
@article{Silva2026,
author = {Silva, Danilo Conceição and Conceição, Vitória Caroline Anjos da and Jesus, Laine Oliveira de and Lima, Maria Jocilene de Jesus and Andrade, Lorena Silva Matos},
title = {O uso indiscriminado de agonistas do GLP-1 (semaglutida e tirzepatida) para o emagrecimento e o papel do farmacêutico na promoção do uso racional},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {158},
pages = {01--19},
doi = {10.69849/d1av6113}
}
EUVIMED